ETON PHARMACEUTICALS INC. - COMMON STOCK
16.67
24-1月-25 15:45:00
15 分の遅延
株式
+0.43
+2.65%
本日の幅
16.32 - 17.01
ISIN
N/A
ソース
NASDAQ
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 6 2021 09:37:52 提供 Nasdaq GlobeNewswire
-
28 5 2021 07:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 5 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 5 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 3 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 3 2021 15:02:00 提供 Nasdaq GlobeNewswire
-
04 3 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 2 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 2 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 1 2021 07:00:01 提供 Nasdaq GlobeNewswire